Abstract

Large burn injuries and wounds contribute to increased patient morbidity and mortality and impose a significant financial burden on healthcare systems. The main goal of wound treatment is to achieve a rapid closure of the lesion and promote healing with minimal scarring. Extracellular matrix- based biomaterials such as acellular dermal matrices (ADM) or in situ-forming scaffolds are advantageous for treatment of large wounds due to their mechanical strength and retained biological activity when compared with synthetic polymer materials. Further, recellularization of ADM with adipose-derived stem cells (ASCs) significantly increases the healing capacity. The aim of this study was to develop an ASC-populated ADM and assess its characteristics in vitro with the ultimate goal of engineering an optimized wound healing composite. To this end, we developed a novel method for de-cellularization of skin and used the acquired ADM as a 3D scaffold to seed human ASCs. We compared this 3D model with traditional 2D ASC cultures at different time points post-culture. A panel of cell surface markers was used for phenotypic characterization of ASCs, post-culture. Combinations of positive (CD146, CD44, CD90, and CD73) and negative (CD31, CD34, CD45) cell surface proteins were used as stem cell markers. Morphology and myofibroblast differentiation capacity of ASCs were also evaluated. The results showed a significant reduction in expression of CD73 and CD44 markers in ASCs when embedded within a 3D ADM, compared to the cells that were cultured in a 2D culture condition. We found that ASCs cultured under regular 2D conditions mainly differentiated towards a myofibroblastic phenotype with increased myofibroblast marker α-smooth muscle actin (α-SMA) and type I pro-collagen. In contrast, ASCs cultured on ADM showed a more balanced differentiation pattern with maintenance of important stem cell markers such as CD146. Taken together, these findings suggest that ASC differentiation can be regulated by a 3D scaffold. Embedding ASCs within 3D scaffolds prevents universal differentiation to stromal cells and maintain stemness features associated with ASCs. The ASC-ADM combination shows a promising potential as a novel therapeutic approach for treatment of large burn injuries and wounds. This bioengineered composite can reduce risk of fibrosis while maintaining the regenerative capacity of stem cells.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.